Patents by Inventor Sylvain Gariel

Sylvain Gariel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11993773
    Abstract: The invention is directed to methods for synthesizing oligonucleotides directly on biomolecules or cells living or fixed. In some embodiments, template-free enzymatic synthesis is implemented under biological conditions with successive cycles of (i) enzymatic addition of a 3?-O-blocked nucleoside triphosphate and (ii) enzymatic deblocking of the incorporated nucleotide to regenerate a free 3? hydroxyl. The invention has applications in single-cell cDNA library construction and analysis.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: May 28, 2024
    Assignee: DNA Script SAS
    Inventors: Xavier Godron, Adrian Horgan, Sylvain Gariel, Jeffrey Jeddeloh, Robert Nicol, Thomas Ybert
  • Patent number: 11685941
    Abstract: The invention relates to a method for synthesising long nucleic acids, including at least one cycle of elongating initial fragments of nucleic acids, including a) a phase comprising the enzymatic addition of nucleotides to said fragments, b) a phase comprising the purification of the fragments having a correct sequence, c) an optional phase of enzymatic amplification, each cycle being performed in a reaction medium which is compatible with enzymatic addition and amplification, such as an aqueous medium, the synthesis method also comprising, at the end of all the elongation cycles, a last step of final amplification. The invention also relates to the use of the method for the production of genes, or sequences of synthetic nucleic acids, DNA or RNA. The invention further relates to a kit for implementing said method.
    Type: Grant
    Filed: October 14, 2020
    Date of Patent: June 27, 2023
    Assignee: DNA Script
    Inventors: Thomas Ybert, Sylvain Gariel
  • Publication number: 20220186213
    Abstract: The invention is directed to methods for synthesizing oligonucleotides direction on biomolecules or cells living or fixed. In some embodiments, template-free enzymatic synthesis is implemented under biological conditions with successive cycles of (i) enzymatic addition of a 3?-O-blocked nucleoside triphosphate and (ii) enzymatic deblocking of the incorporated nucleotide to regenerate a free 3? hydroxyl. The invention has applications in single-cell cDNA library construction and analysis.
    Type: Application
    Filed: March 4, 2022
    Publication date: June 16, 2022
    Applicant: DNA Script SAS
    Inventors: Xavier Godron, Adrian Horgan, Sylvain Gariel, Jeffrey Jeddeloh, Robert Nicol, Thomas Ybert
  • Patent number: 11268091
    Abstract: The invention is directed to methods for synthesizing oligonucleotides directly on biomolecules or cells living or fixed. In some embodiments, template-free enzymatic synthesis is implemented under biological conditions with successive cycles of (i) enzymatic addition of a 3?-O-blocked nucleoside triphosphate and (ii) enzymatic deblocking of the incorporated nucleotide to regenerate a free 3? hydroxyl. The invention has applications in single-cell cDNA library construction and analysis.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: March 8, 2022
    Assignee: DNA Script SAS
    Inventors: Xavier Godron, Adrian Horgan, Sylvain Gariel, Jeffrey Jeddeloh, Robert Nicol, Thomas Ybert
  • Patent number: 11059849
    Abstract: A modified nucleotide, intended for the synthesis of long chain nucleic acids by enzymatic processes, comprising a “natural” nitrogenous base or a natural nitrogenous base analogue, a ribose or deoxyribose carbohydrate, and at least one phosphate group, characterized in that said nucleotide comprises at least one R group, termed the modifier group, carried by said nitrogenous base or analogue and/or by the oxygen in position 3? of the ribose or deoxyribose molecule, making it possible to block the polymerization of said nucleotide and/or to allow the interaction of said nucleotide with another molecule, such as a protein, during the nucleic acid synthesis, R comprising at least one functional terminal group.
    Type: Grant
    Filed: September 1, 2015
    Date of Patent: July 13, 2021
    Assignee: DNA Script
    Inventors: Thomas Ybert, Sylvain Gariel
  • Publication number: 20210198661
    Abstract: The invention is directed to methods for synthesizing oligonucleotides direction on biomolecules or cells living or fixed. In some embodiments, template-free enzymatic synthesis is implemented under biological conditions with successive cycles of (i) enzymatic addition of a 3?-O-blocked nucleoside triphosphate and (ii) enzymatic deblocking of the incorporated nucleotide to regenerate a free 3? hydroxyl. The invention has applications in single-cell cDNA library construction and analysis.
    Type: Application
    Filed: March 4, 2021
    Publication date: July 1, 2021
    Applicant: DNA Script SAS
    Inventors: Xavier Godron, Adrian Horgan, Sylvain Gariel, Jeffrey Jeddaloh, Robert Nicol, Thomas Ybert
  • Publication number: 20210130863
    Abstract: The invention relates to a method for synthesising long nucleic acids, including at least one cycle of elongating initial fragments of nucleic acids, including a) a phase comprising the enzymatic addition of nucleotides to said fragments, b) a phase comprising the purification of the fragments having a correct sequence, c) an optional phase of enzymatic amplification, each cycle being performed in a reaction medium which is compatible with enzymatic addition and amplification, such as an aqueous medium, the synthesis method also comprising, at the end of all the elongation cycles, a last step of final amplification. The invention also relates to the use of the method for the production of genes, or sequences of synthetic nucleic acids, DNA or RNA. The invention further relates to a kit for implementing said method.
    Type: Application
    Filed: October 14, 2020
    Publication date: May 6, 2021
    Inventors: Thomas Ybert, Sylvain Gariel
  • Patent number: 10913964
    Abstract: The invention relates to a method for synthesising long nucleic acids, including at least one cycle of elongating initial fragments of nucleic acids, including a) a phase comprising the enzymatic addition of nucleotides to said fragments, b) a phase comprising the purification of the fragments having a correct sequence, c) an optional phase of enzymatic amplification, each cycle being performed in a reaction medium which is compatible with enzymatic addition and amplification, such as an aqueous medium, the synthesis method also comprising, at the end of all the elongation cycles, a last step of final amplification. The invention also relates to the use of the method for the production of genes, or sequences of synthetic nucleic acids, DNA or RNA. The invention further relates to a kit for implementing said method.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: February 9, 2021
    Assignee: DNA Script
    Inventors: Thomas Ybert, Sylvain Gariel
  • Publication number: 20210009994
    Abstract: The invention is directed to methods for synthesizing oligonucleotides direction on biomolecules or cells living or fixed. In some embodiments, template-free enzymatic synthesis is implemented under biological conditions with successive cycles of (i) enzymatic addition of a 3?-O-blocked nucleoside triphosphate and (ii) enzymatic deblocking of the incorporated nucleotide to regenerate a free 3? hydroxyl. The invention has applications in single-cell cDNA library construction and analysis.
    Type: Application
    Filed: December 10, 2019
    Publication date: January 14, 2021
    Applicant: DNA Script SAS
    Inventors: Xavier Godron, Adrian Horgan, Sylvain Gariel, Jeffrey Jeddaloh, Robert Nicol, Thomas Ybert
  • Patent number: 10837040
    Abstract: The invention relates to a method for synthesising long nucleic acids, including at least one cycle of elongating initial fragments of nucleic acids, including a) a phase comprising the enzymatic addition of nucleotides to said fragments, b) a phase comprising the purification of the fragments having a correct sequence, c) an optional phase of enzymatic amplification, each cycle being performed in a reaction medium which is compatible with enzymatic addition and amplification, such as an aqueous medium, the synthesis method also comprising, at the end of all the elongation cycles, a last step of final amplification. The invention also relates to the use of the method for the production of genes, or sequences of synthetic nucleic acids, DNA or RNA. The invention further relates to a kit for implementing said method.
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: November 17, 2020
    Assignee: DNA Script
    Inventors: Thomas Ybert, Sylvain Gariel
  • Publication number: 20200231619
    Abstract: A modified nucleotide, intended for the synthesis of long chain nucleic acids by enzymatic processes, comprising a “natural” nitrogenous base or a natural nitrogenous base analogue, a ribose or deoxyribose carbohydrate, and at least one phosphate group, characterized in that said nucleotide comprises at least one R group, termed the modifier group, carried by said nitrogenous base or analogue and/or by the oxygen in position 3? of the ribose or deoxyribose molecule, making it possible to block the polymerization of said nucleotide and/or to allow the interaction of said nucleotide with another molecule, such as a protein, during the nucleic acid synthesis, R comprising at least one functional terminal group.
    Type: Application
    Filed: September 1, 2015
    Publication date: July 23, 2020
    Inventors: Thomas YBERT, Sylvain GARIEL
  • Publication number: 20190300923
    Abstract: The invention relates to a method for synthesising long nucleic acids, including at least one cycle of elongating initial fragments of nucleic acids, including a) a phase comprising the enzymatic addition of nucleotides to said fragments, b) a phase comprising the purification of the fragments having a correct sequence, c) an optional phase of enzymatic amplification, each cycle being performed in a reaction medium which is compatible with enzymatic addition and amplification, such as an aqueous medium, the synthesis method also comprising, at the end of all the elongation cycles, a last step of final amplification. The invention also relates to the use of the method for the production of genes, or sequences of synthetic nucleic acids, DNA or RNA. The invention further relates to a kit for implementing said method.
    Type: Application
    Filed: April 15, 2015
    Publication date: October 3, 2019
    Inventors: Thomas Ybert, Sylvain Gariel
  • Publication number: 20190264248
    Abstract: The invention relates to a method for synthesising long nucleic acids, including at least one cycle of elongating initial fragments of nucleic acids, including a) a phase comprising the enzymatic addition of nucleotides to said fragments, b) a phase comprising the purification of the fragments having a correct sequence, c) an optional phase of enzymatic amplification, each cycle being performed in a reaction medium which is compatible with enzymatic addition and amplification, such as an aqueous medium, the synthesis method also comprising, at the end of all the elongation cycles, a last step of final amplification. The invention also relates to the use of the method for the production of genes, or sequences of synthetic nucleic acids, DNA or RNA. The invention further relates to a kit for implementing said method.
    Type: Application
    Filed: December 11, 2018
    Publication date: August 29, 2019
    Inventors: Thomas Ybert, Sylvain Gariel